BioLife Solutions Statistics Share Statistics BioLife Solutions has 47.84M
shares outstanding. The number of shares has increased by 3.08%
in one year.
Shares Outstanding 47.84M Shares Change (YoY) 3.08% Shares Change (QoQ) 1.19% Owned by Institutions (%) 99.99% Shares Floating 45.96M Failed to Deliver (FTD) Shares 356 FTD / Avg. Volume 0.07%
Short Selling Information The latest short interest is 4.23M, so 8.89% of the outstanding
shares have been sold short.
Short Interest 4.23M Short % of Shares Out 8.89% Short % of Float 13.13% Short Ratio (days to cover) 9.83
Valuation Ratios The PE ratio is -59.25 and the forward
PE ratio is 284.
BioLife Solutions's PEG ratio is
0.83.
PE Ratio -59.25 Forward PE 284 PS Ratio 14.54 Forward PS 9 PB Ratio 3.43 P/FCF Ratio 229.8 PEG Ratio 0.83
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for BioLife Solutions.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.54,
with a Debt / Equity ratio of 0.09.
Current Ratio 4.54 Quick Ratio 3.66 Debt / Equity 0.09 Debt / EBITDA 19.7 Debt / FCF 5.8 Interest Coverage -9.92
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $517.32K Profits Per Employee $-126.94K Employee Count 159 Asset Turnover 0.21 Inventory Turnover 0.84
Taxes Income Tax -38K Effective Tax Rate 0.33%
Stock Price Statistics The stock price has increased by -13.06% in the
last 52 weeks. The beta is 1.76, so BioLife Solutions's
price volatility has been higher than the market average.
Beta 1.76 52-Week Price Change -13.06% 50-Day Moving Average 21.89 200-Day Moving Average 24.24 Relative Strength Index (RSI) 57.68 Average Volume (20 Days) 531,627
Income Statement In the last 12 months, BioLife Solutions had revenue of 82.25M
and earned -20.18M
in profits. Earnings per share was -0.44.
Revenue 82.25M Gross Profit 57.75M Operating Income -7.13M Net Income -20.18M EBITDA 1.53M EBIT -7.13M Earnings Per Share (EPS) -0.44
Full Income Statement Balance Sheet The company has 95.39M in cash and 30.17M in
debt, giving a net cash position of 65.21M.
Cash & Cash Equivalents 95.39M Total Debt 30.17M Net Cash 65.21M Retained Earnings -335.1M Total Assets 395.14M Working Capital 103.41M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 8.43M
and capital expenditures -3.23M, giving a free cash flow of 5.2M.
Operating Cash Flow 8.43M Capital Expenditures -3.23M Free Cash Flow 5.2M FCF Per Share 0.11
Full Cash Flow Statement Margins Gross margin is 70.21%, with operating and profit margins of -8.67% and -24.54%.
Gross Margin 70.21% Operating Margin -8.67% Pretax Margin -13.89% Profit Margin -24.54% EBITDA Margin 1.86% EBIT Margin -8.67% FCF Margin 6.33%
Dividends & Yields BLFS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for BLFS is $31.5,
which is 40.4% higher than the current price. The consensus rating is "Buy".
Price Target $31.5 Price Target Difference 40.4% Analyst Consensus Buy Analyst Count 7
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 29, 2014. It was a
backward
split with a ratio of 1:14.
Last Split Date Jan 29, 2014 Split Type backward Split Ratio 1:14
Scores Altman Z-Score 13.22 Piotroski F-Score 5
